GGHC
STDY

Gilder Gagnon Howe & Co’s SteadyMed Ltd STDY Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,512
Closed -$31K – 316
2017
Q4 		$31K Sell
8,512
-12,984
-60% -$41.9K ﹤0.01% 290
2017
Q3 		$72K Buy
21,496
+9,926
+86% +$52.8K ﹤0.01% 269
2017
Q2 		$73K Buy
+11,570
New +$78.7K ﹤0.01% 272

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Gilder Gagnon Howe & Co's STDY Position: Q1 2018 in Review

Gilder Gagnon Howe & Co sold out of SteadyMed Ltd (STDY) in Q1 2018, closing a stake of 8,512 shares — an estimated $31K sold.

Gilder Gagnon Howe & Co first reported a position in STDY in Q2 2017 and held it in 3 quarters. The position peaked at $73K in Q2 2017. 25 funds tracked by Wall St. Rank hold STDY as of Q1 2018.

  • Gilder Gagnon Howe & Co reported no remaining SteadyMed Ltd position as of Q1 2018 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 8,512 SteadyMed Ltd shares in Q1 2018, an estimated $31K.
  • Gilder Gagnon Howe & Co first reported a position in SteadyMed Ltd in Q2 2017 and held it in 3 quarters.
  • Gilder Gagnon Howe & Co's SteadyMed Ltd position peaked at $73K in Q2 2017.
  • 25 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q1 2018.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2018, filed 30 Apr 2018.